Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiology ; 149(1): 40-50, 2024.
Article in English | MEDLINE | ID: mdl-37944497

ABSTRACT

INTRODUCTION: To study the prognostic factors of patients with chest pain and without obstructive coronary artery disease is of great significance for the management of such patients. We assessed whether a high-sensitivity troponin I (hs-TnI) is associated with prognosis in patients with chest pain and without obstructive coronary artery disease. METHODS: From 2011 to 2017, 489 consecutively hospitalized patients with chest pain and without significant coronary artery stenosis (<50%) were tested for hs-TnI and underwent stress myocardial contrast echocardiography (MCE). Myocardial blood flow reserve (MBFR) was measured by stress MCE. Patients were followed (median, 41 months) for composite endpoints, including cardiovascular death and non-fatal myocardial infarction. Cox proportional hazards models were performed to determine associations between hs-TnI and the composite endpoints. RESULTS: Among 489 patients with chest pain and without significant coronary artery stenosis, 257 patients (52.6%) had elevated hs-TnI. Compared to patients with normal hs-TnI, patients with elevated hs-TnI were older (p = 0.013) and had a higher prevalence of atrial fibrillation (p = 0.003), higher left ventricular mass index (p = 0.002) and E/e' septal (p < 0.001), and a lower MBFR (p < 0.001). After adjustment, there was still a significant association between hs-TnI and MBFR (odds ratio = 1.145; 95% confidence interval [CI], 1.079-1.214; p < 0.001). Compared with patients with normal hs-TnI, patients with elevated hs-TnI had a greater cumulative event rate (log-rank p = 0.002). Males (hazard ratio [HR], 4.770; 95% CI, 1.175-19.363; p = 0.029) and reduced MBFR (HR, 2.496; 95% CI, 1.446-4.311; p = 0.001) were risk factors associated with composite endpoints in patients with elevated hs-TnI. CONCLUSIONS: In patients with chest pain and without obstructive coronary artery disease, elevated hs-TnI is associated with decreased myocardial perfusion by contrast echocardiography as well as a higher incidence of cardiovascular events.


Subject(s)
Coronary Artery Disease , Coronary Stenosis , Myocardial Infarction , Male , Humans , Coronary Artery Disease/diagnostic imaging , Myocardial Infarction/epidemiology , Prognosis , Troponin I , Coronary Stenosis/diagnostic imaging , Chest Pain/etiology , Biomarkers
2.
Respir Physiol Neurobiol ; 299: 103843, 2022 05.
Article in English | MEDLINE | ID: mdl-35026480

ABSTRACT

Ganoderma, a fungal genus, is a traditional medicine with immuno-modulating effects. Asthma is an inflammatory disease of airways, and the main trigger of asthma is allergic inflammation. In this study, the effects of Ganoderma (an anti-inflammatory agent) given via oral administration (G/O) or intraperitoneal injection (G/IP) on asthma was evaluated. Forty BALB/c mice were divided into four groups, including the control, OVA-challenge, OVA-challenge + G/O, and OVA-challenge + G/IP. To determine AHR, the MCh challenge test was done. The levels of IL-1ß, -4, -5, -6, -8, -10, -12, -13, -17, -25, -33, -38, Cys-LT, LTB4, and hydroxyproline were measured. Finally, lung histopathology was evaluated to determine eosinophilic inflammation, goblet cell hyperplasia, and mucus hyper-secretion. Treatment with G/O and G/IP could significantly reduce the levels of IL-1ß, -5, -6, -8, -17, -25, -33, and -38; the levels of IL-4 and IL-13 had no significant changes, but the levels of IL-10 and IL-12 were enhanced. The mice treated with G/O and G/IP showed decreased levels of Cys-LT, LTB4, peribronchial and perivascular inflammation, but no significant changes were observed in AHR, hydroxyproline level, goblet cell hyperplasia, and mucus hyper-secretion. Ganoderma can be applied as an immunomodulatory and anti-inflammatory agent for managing asthma.


Subject(s)
Asthma , Ganoderma , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Asthma/drug therapy , Asthma/pathology , Bronchoalveolar Lavage Fluid , Cytokines , Disease Models, Animal , Hydroxyproline/therapeutic use , Hyperplasia/pathology , Inflammation/drug therapy , Inflammation/pathology , Leukotriene B4/therapeutic use , Lung/pathology , Mice , Mice, Inbred BALB C , Ovalbumin
3.
Clin Biochem ; 87: 46-51, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33188773

ABSTRACT

BACKGROUND: Leptin, adiponectin, secreted frizzled-related protein 5 (Sfrp5) and wingless-type family member 5a (Wnt5a) are novel adipokines that are involved in insulin sensitivity and atherosclerosis. The aim of the present study was to investigate the serum and periarterial adipose tissue leptin/adiponectin and Sfrp5/Wnt5a levels in patients with peripheral arterial occlusive disease (PAOD). METHODS: A total of 75 patients with PAOD and 39 control subjects were recruited. The serum concentrations of leptin, adiponectin, Sfrp5 and Wnt5a were measured by ELISAs, and the leptin, adiponectin, Sfrp5 and Wnt5a levels in the periarterial adipose tissue were observed by western blotting. RESULTS: The serum Sfrp5 levels were significantly lower in the patients with PAOD than in the control subjects (p < 0.001) and Wnt5a levels were higher in the patients with PAOD (p < 0.001). The serum leptin levels were significantly higher in the patients with PAOD than in the control subjects (p < 0.001), and adiponectin levels were significantly lower in the patients with PAOD (p < 0.001). The serum Sfrp5 levels were associated with ABI (rs = 0.274; p = 0.018), Wnt5a (rs = -0.409; p < 0.001), adiponectin (rs = 0.244; p = 0.035) and Leptin/Adiponetin ratio (rs = -0.244; p = 0.037). The adiponectin and Sfrp5 protein levels were decreased in the periarterial adipose tissue of patients with PAOD compared with control subjects. The leptin and Wnt5a protein levels were increased in the periarterial adipose tissue of patients with PAOD compared with control subjects. CONCLUSION: We demonstrated that the adiponectin and Sfrp5 levels in the serum and periarterial adipose tissue were significantly lower in the patients with PAOD than in the control subjects. The leptin and Wnt5a levels in the serum and periarterial adipose tissue were significantly higher in the patients with PAOD than in the control subjects.


Subject(s)
Adaptor Proteins, Signal Transducing/blood , Adiponectin/blood , Adipose Tissue/metabolism , Arterial Occlusive Diseases/pathology , Leptin/blood , Peripheral Arterial Disease/pathology , Wnt-5a Protein/blood , Adipose Tissue/pathology , Aged , Arterial Occlusive Diseases/blood , Biomarkers/blood , Body Mass Index , Case-Control Studies , Female , Humans , Insulin Resistance , Male , Peripheral Arterial Disease/blood
4.
J Int Med Res ; 48(8): 300060520933816, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32776784

ABSTRACT

We herein report two cases of paradoxical carbon dioxide (CO2) embolism during laparoscopic nephrectomy and hepatic left lateral lobectomy without evidence of a right-to-left shunt or obvious rupture of blood vessels. Transesophageal echocardiography detected paradoxical CO2 embolism before the end-tidal CO2 partial pressure (PETCO2) dropped from baseline. The pneumoperitoneum was reduced or stopped immediately after detection of the embolism. One patient developed a postoperative epileptiform seizure. In the other patient, many gas bubbles were drawn out from the central venous line. We speculate that rapid introduction of pneumoperitoneum pushed a large amount of CO2 into the abdominal blood vessels, exceeding the gas exchange capacity of the lung and causing CO2 bubble formation in the left-side cardiac system. These two cases indicate that intraoperative transesophageal echocardiography can reduce the influence of CO2 embolism during laparoscopic tumor surgery by early diagnosis of the embolism and provide helpful information to establish a list of differential diagnoses of postoperative complications.


Subject(s)
Embolism, Air , Laparoscopy , Carbon Dioxide , Echocardiography, Transesophageal , Embolism, Air/diagnostic imaging , Embolism, Air/etiology , Hepatectomy , Humans , Pneumoperitoneum, Artificial
5.
Medicine (Baltimore) ; 98(27): e15990, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31277090

ABSTRACT

BACKGROUND: Recent studies have demonstrated that coronary microcirculation dysfunction (CMVD) is closely correlated with adverse clinical outcomes. In this study, quantitative stress myocardial contrast echocardiography (MCE) was used to evaluate the CMVD and to investigate its association with the prognosis of patients with nonobstructive coronary artery disease (CAD). MATERIAL AND METHODS: From 2006 to 2014, 227 consecutive patients with chest pain and a diagnostic coronary angiography without significant coronary artery stenosis (<50%) who underwent adenosine triphosphate disodium (ATP) stress MCE were enrolled. Quantitative MCE measurements were analyzed using replenishment curves. RESULTS: Median follow-up time of this study was 5.3 years. Predictors of impaired coronary flow reserve (CFR) were smoking, diabetes, high apolipoprotein B, high low-density lipoprotein, serum uric acid, and low apolipoprotein A. During follow-up, 22 patients were reported to have 30 cardiac events (21 unstable angina, 3 nonfatal myocardial infarctions, 6 percutaneous coronary interventions). Using multivariate analysis, abnormal ß reserve (≤1.6), impaired CFR (≤2.0), and diabetes were independent predictors of primary endpoint events in patients with nonobstructive CAD (P < .05). Multivariate analysis showed that CFR ≤2.0 (odds ratio [OR] =  25.21, 95% confidence interval [CI]: 3.01-182.32; P = .003), ß reserve ≤1.6 (OR = 29.96, 95% CI: 3.5-241.27; P = .002), and diabetic (OR = 33.11, 95% CI: 3.65-300.02; P = .002) significantly increased the risk of the primary endpoint events. CONCLUSIONS: ATP stress quantitative MCE is a feasible and effective method to evaluate microcirculation abnormalities in human coronary arteries and it can be used for the clinical analysis, risk stratification, and treatment of early CAD.


Subject(s)
Coronary Artery Disease/diagnostic imaging , Coronary Stenosis/diagnostic imaging , Echocardiography, Stress/methods , Echocardiography/methods , Microcirculation/physiology , Adenosine Triphosphate/administration & dosage , Adult , Aged , Female , Humans , Male , Middle Aged , ROC Curve , Risk Factors
6.
Pacing Clin Electrophysiol ; 40(9): 986-994, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28691201

ABSTRACT

BACKGROUND: 20-30% of patients do not benefit from cardiac resynchronization therapy (CRT) when the established selection criteria were applied. We hypothesized that a combined assessment of mechanical dyssynchrony, myocardial deformation, and diastolic function would identify patients who would benefit most from CRT. METHOD: In 36 CRT patients, clinical evaluation and echocardiography were performed before and after CRT. Patients were classified into three subgroups according to their amount of response: echocardiographic responders, clinical responders, and nonresponders. Radial dyssynchrony and left ventricular (LV) global longitudinal, radial, and circumferential peak strain was assessed by speckle-tracking image. Diastolic function was quantified by conventional echocardiography. RESULT: In addition to left bundle branch block, nonspecific intraventricular conduction disturbance with intraventricular dyssynchrony could also improve LV remodeling. Echocardiographic responders had better global longitudinal strain, global circumferential peak strain, and global radial strain at baseline which significantly increased at 12-month follow-up. An improvement in estimates of LV filling pressure and a decrease in mitral regurgitation and left atrial dimensions were observed only in echocardiographic responders to CRT. Patients with clinical but without echocardiographic response showed a significant improvement in atrioventricular (AV) synchrony and a nonsignificant improvement in other parameters. The nonresponder group did not improve the AV and intraventricular dyssynchrony. CRT could not improve restrictive filling pattern with normal filling time. Overall, those patients with AV and intraventricular dyssynchrony and those with best contractile function and short diastolic filling time of restrictive filling pattern at baseline demonstrated the greatest benefit from CRT. CONCLUSIONS: Mechanical dyssynchrony, contractile function, and filling pattern are important determinants of the benefits in CRT.


Subject(s)
Cardiac Resynchronization Therapy , Cardiomyopathies/physiopathology , Cardiomyopathies/therapy , Cardiomyopathies/diagnostic imaging , Echocardiography , Female , Heart Function Tests , Humans , Male , Middle Aged , Patient Selection
7.
Clin Respir J ; 9(2): 165-75, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24517735

ABSTRACT

BACKGROUND AND AIMS: In recent years, some epidemiological surveys of risk factors for chronic obstructive pulmonary disease (COPD) have been done in some regions of China, but the relevance is shown different in these surveys. A meta-analysis was undertaken to assess the relationship between smoking and COPD in Chinese population. METHODS: Twenty-four papers were included in our study. Total number of ever smokers and never smokers were 34,191 and 58,854, the number of COPD cases in each group were 5843 and 4874, respectively. We used meta-analysis method to analyze the selected papers quantitatively, and stratified by type of study, gender and smoking index. RESULTS: Risk of COPD for ever smokers is higher than never smokers [odds ratio (OR) 2.90, 95% confidence interval (CI) 2.22 ∼ 3.80]; after stratifying by gender and smoking index, risks of COPD for male and female ever smokers are higher than male and female never smokers (OR 1.93, 95%CI 1.35 ∼ 2.77; OR 2.67, 95%CI 2.01 ∼ 3.56, respectively); risks of COPD for ever smokers who belong to different smoking index group (1 ∼ 200, 200 ∼ 400, >400, <300, ≥300 cigarettes per day*year) are all higher than never smokers (OR 2.49, 95%CI 1.66 ∼ 3.74; OR 2.91, 95%CI 2.19 ∼ 3.87; OR 4.07, 95%CI 3.17 ∼ 5.23; OR 2.39, 95%CI 1.42 ∼ 4.02; OR 3.31, 95%CI 2.99 ∼ 3.66, respectively). CONCLUSIONS: The risk of COPD is higher for ever smokers than never smokers in Chinese population. The risk of COPD is higher for female smokers than male smokers. The risk of COPD is higher with greater smoking index.


Subject(s)
Asian People/statistics & numerical data , Pulmonary Disease, Chronic Obstructive/epidemiology , Smoking/epidemiology , China/epidemiology , Female , Humans , Male , Odds Ratio , Risk Factors , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...